Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 5Stomach Neoplasms 3Malnutrition 2Carcinoma, Hepatocellular 2Psychological Well-Being 1Motor Activity 1Lung Neoplasms 1Liver Cirrhosis 1Gastrointestinal Neoplasms 1Fibrosis 1Esophageal Neoplasms 1Endotoxemia 1Diarrhea 1Anus Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Probiotics × Gastrointestinal × Clear all
NCT03853928 2019-02-27

Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis

Austral University, Argentina

Phase NA Unknown
280 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT02021253 2018-05-15

LIPROCES

University Hospital, Rouen

Phase NA Completed
64 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Endotoxemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡